CN102089295A - 治疗用取代的噻唑烷酮、噁唑烷酮和相关化合物 - Google Patents

治疗用取代的噻唑烷酮、噁唑烷酮和相关化合物 Download PDF

Info

Publication number
CN102089295A
CN102089295A CN2009801268503A CN200980126850A CN102089295A CN 102089295 A CN102089295 A CN 102089295A CN 2009801268503 A CN2009801268503 A CN 2009801268503A CN 200980126850 A CN200980126850 A CN 200980126850A CN 102089295 A CN102089295 A CN 102089295A
Authority
CN
China
Prior art keywords
compound
another embodiment
phenyl
compounds
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2009801268503A
Other languages
English (en)
Chinese (zh)
Inventor
D·W·奥尔德
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Inc
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of CN102089295A publication Critical patent/CN102089295A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/32—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
CN2009801268503A 2008-05-09 2009-05-06 治疗用取代的噻唑烷酮、噁唑烷酮和相关化合物 Pending CN102089295A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5181708P 2008-05-09 2008-05-09
US61/051,817 2008-05-09
PCT/US2009/042930 WO2009137544A1 (en) 2008-05-09 2009-05-06 Therapeutic substituted thiazolidinones, oxazolidinones, and related compounds

Publications (1)

Publication Number Publication Date
CN102089295A true CN102089295A (zh) 2011-06-08

Family

ID=40726702

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009801268503A Pending CN102089295A (zh) 2008-05-09 2009-05-06 治疗用取代的噻唑烷酮、噁唑烷酮和相关化合物

Country Status (10)

Country Link
US (1) US7786117B2 (pt)
EP (1) EP2285796A1 (pt)
JP (1) JP2011520811A (pt)
KR (1) KR20110017878A (pt)
CN (1) CN102089295A (pt)
AU (1) AU2009244325B2 (pt)
BR (1) BRPI0912342A2 (pt)
CA (1) CA2728229A1 (pt)
RU (1) RU2010149494A (pt)
WO (1) WO2009137544A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9540357B1 (en) 2014-07-31 2017-01-10 Allergan, Inc. 15-aryl prostaglandins as EP4 agonists, and methods of use thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008024765A2 (en) * 2006-08-23 2008-02-28 Allergan, Inc. Therapeutic substituted thiazolidinones, oxazolidinones, and related compounds

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2915527A (en) * 1959-12-01 Oxazolidone compounds and means for
US4166452A (en) * 1976-05-03 1979-09-04 Generales Constantine D J Jr Apparatus for testing human responses to stimuli
US4022794A (en) * 1976-05-24 1977-05-10 Merck & Co., Inc. Novel analogs of prostaglandins with 4-oxo-thiazolidinyl nucleus and method of preparation thereof
US4256108A (en) * 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
US4265874A (en) * 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US4543353A (en) * 1981-11-27 1985-09-24 Farmitalia Carlo Erba S.P.A. Ester and amide derivatives of 13,14-didehydro prostaglandins
JPH0692305B2 (ja) * 1987-05-15 1994-11-16 株式会社上野製薬応用研究所 体温上昇剤
JP2597649B2 (ja) * 1988-05-11 1997-04-09 株式会社上野製薬応用研究所 気管・気管支拡張剤
US6437146B1 (en) * 1998-09-25 2002-08-20 Fujisawa Pharmaceutical Co., Ltd. Oxazole compounds as prostaglandin e2 agonists or antagonists
MXPA04004164A (es) * 2001-11-05 2004-09-06 Allergan Inc Analogos de omega-cicloalquil 17-heteroaril prostaglandina e2 como agonistas del receptor ep2.
WO2006050459A2 (en) * 2004-10-28 2006-05-11 Cook Incorporated Methods and systems for modifying vascular valves
WO2008094912A2 (en) * 2007-01-31 2008-08-07 Allergan, Inc. Substituted gamma lactams as therapeutic agents

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008024765A2 (en) * 2006-08-23 2008-02-28 Allergan, Inc. Therapeutic substituted thiazolidinones, oxazolidinones, and related compounds

Also Published As

Publication number Publication date
EP2285796A1 (en) 2011-02-23
CA2728229A1 (en) 2009-11-12
US7786117B2 (en) 2010-08-31
AU2009244325A1 (en) 2009-11-12
KR20110017878A (ko) 2011-02-22
AU2009244325B2 (en) 2014-09-25
BRPI0912342A2 (pt) 2015-10-06
US20090281171A1 (en) 2009-11-12
JP2011520811A (ja) 2011-07-21
WO2009137544A1 (en) 2009-11-12
RU2010149494A (ru) 2012-06-20

Similar Documents

Publication Publication Date Title
US7737140B2 (en) Therapeutic compounds
US7964599B2 (en) Therapeutic compounds
EP2285775A1 (en) Therapeutic lactams
US7960379B2 (en) Therapeutic compounds
CN102089295A (zh) 治疗用取代的噻唑烷酮、噁唑烷酮和相关化合物
US8633310B2 (en) Therapeutic substituted lactams
US7981887B2 (en) Therapeutic compounds
US8093282B2 (en) Therapeutic N-aryl or N-heteroaryl pyrazolidine and pyrazolidinone derivatives
US7964596B2 (en) Therapeutic compounds
US8198318B2 (en) Therapeutic amides
US8530471B2 (en) Therapeutic cyclopentane derivatives
JP2011520807A (ja) 治療用置換ヒダントイン類および関連化合物
EP2247583A1 (en) Hydrazines in glaucoma therapy

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20110608